Mantech Pharmacia Profile
Key Indicators
- Authorised Capital ₹ 1.10 Cr
as on 11-12-2024
- Paid Up Capital ₹ 1.08 Cr
as on 11-12-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.01 M
as on 11-12-2024
- Revenue 10.37%
(FY 2022)
- Profit 13.54%
(FY 2022)
- Ebitda 557.57%
(FY 2022)
- Net Worth 30.36%
(FY 2022)
- Total Assets 1.47%
(FY 2022)
About Mantech Pharmacia
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.10 Cr and a paid-up capital of Rs 1.08 Cr.
The company currently has active open charges totaling ₹9.01 M.
Leela Krishna, Atul Kumar, Rahul Varshney, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909UP2018PTC101291
- Company No.
101291
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Aligarh, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mantech Pharmacia?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Leela Krishna  | Director | 23-Feb-2018 | Current |
| Atul Kumar | Director | 23-Feb-2018 | Current |
| Rahul Varshney | Director | 23-Feb-2018 | Current |
| Agam Agarwal | Director | 12-Apr-2019 | Current |
Financial Performance of Mantech Pharmacia.
Mantech Pharmacia Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.37% increase. The company also saw a substantial improvement in profitability, with a 13.54% increase in profit. The company's net worth Soared by an impressive increase of 30.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mantech Pharmacia?
In 2021, Mantech Pharmacia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Novitech Health Care Private LimitedActive 14 years 2 monthsLeela Krishna and Atul Kumar are mutual person
Ion Healthcare Private LimitedActive 20 years 7 monthsLeela Krishna, Atul Kumar and 1 more are mutual person
Leegaa Vital Biosciences Private LimitedActive 2 years 4 monthsLeela Krishna and Atul Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Jun 2024 | ₹8.00 M | Open |
Hdfc Bank Limited Creation Date: 18 Oct 2022 | ₹1.01 M | Open |
How Many Employees Work at Mantech Pharmacia?
Unlock and access historical data on people associated with Mantech Pharmacia, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mantech Pharmacia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mantech Pharmacia's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
